News 

05.04.2022

Dao Tun advised Quimatryx in a 92 million dollars licensing deal for a cancer drug

22.03.2022

Dao Tun forms strategic partnership with Viopas Venture Consulting 

31.01.2022

Dao Tun GmbH welcomes Dr. Ulf Grawunder as new Advisor to the Team 

04.12.2018

Dao Tun CEO Tianke Wang interviewed in industry publication "Labiotech.eu"